Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinier G S Meester

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The Lancet. Gastroenterology & Hepatology|March 21, 2020
Sessile serrated polyps and colorectal cancer mortalityReinier G S Meester, Uri Ladabaum
JNCI Cancer Spectrum|September 6, 2024
Impact of the serrated pathway on the simulated comparative effectiveness of colorectal cancer screening testsReinier G S Meester, Uri Ladabaum
Gastroenterology|February 5, 2022
Long-Term Risk for Colorectal Cancer in Patients With Index Serrated PolypsReinier G S Meester, Joseph C Anderson
Best Practice & Research. Clinical Gastroenterology|December 13, 2016
Cost effectiveness of surveillance for GI cancersAmir-Houshang Omidvari, Reinier G S Meester, Iris Lansdorp-Vogelaar
The American Journal of Gastroenterology|October 14, 2024
Response to Shiratori et alReinier G S Meester, Sidney J Winawer, Ann G Zauber
JAMA|May 22, 2019
Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years, 1975-2015Reinier G S Meester, Ajitha Mannalithara, Iris Lansdorp-Vogelaar, et al.
Gastroenterology|April 2, 2019
Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 YearsUri Ladabaum, Ajitha Mannalithara, Reinier G S Meester, et al.
Journal of the National Cancer Institute|March 18, 2026
RE: the centers for medicare and medicaid services and others misunderstand stool testing for colorectal cancerAndrew J Piscitello, David K Edwards V, Signe Fransen, et al.
Gastroenterology|October 8, 2019
ReplyUri Ladabaum, Ajitha Mannalithara, Reinier G S Meester, et al.
Plos One|July 12, 2021
Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model explorationAmir-Houshang Omidvari, Iris Lansdorp-Vogelaar, Harry J de Koning, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The Lancet. Gastroenterology & Hepatology|March 21, 2020
Sessile serrated polyps and colorectal cancer mortalityReinier G S Meester, Uri Ladabaum
JNCI Cancer Spectrum|September 6, 2024
Impact of the serrated pathway on the simulated comparative effectiveness of colorectal cancer screening testsReinier G S Meester, Uri Ladabaum
Gastroenterology|February 5, 2022
Long-Term Risk for Colorectal Cancer in Patients With Index Serrated PolypsReinier G S Meester, Joseph C Anderson
Best Practice & Research. Clinical Gastroenterology|December 13, 2016
Cost effectiveness of surveillance for GI cancersAmir-Houshang Omidvari, Reinier G S Meester, Iris Lansdorp-Vogelaar
The American Journal of Gastroenterology|October 14, 2024
Response to Shiratori et alReinier G S Meester, Sidney J Winawer, Ann G Zauber
JAMA|May 22, 2019
Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years, 1975-2015Reinier G S Meester, Ajitha Mannalithara, Iris Lansdorp-Vogelaar, et al.
Gastroenterology|April 2, 2019
Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 YearsUri Ladabaum, Ajitha Mannalithara, Reinier G S Meester, et al.
Journal of the National Cancer Institute|March 18, 2026
RE: the centers for medicare and medicaid services and others misunderstand stool testing for colorectal cancerAndrew J Piscitello, David K Edwards V, Signe Fransen, et al.
Gastroenterology|October 8, 2019
ReplyUri Ladabaum, Ajitha Mannalithara, Reinier G S Meester, et al.
Plos One|July 12, 2021
Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model explorationAmir-Houshang Omidvari, Iris Lansdorp-Vogelaar, Harry J de Koning, et al.
Pageof 5